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FAILURE OF RENAL HOMOGRAFT PROTECTION WITH RNA PRETREATMENT! 
Nine years ago Groth et al. (8) reported from our laboratories 
that infusion of canine renal and hepatic homografts with 
solutions containing RNA of either donor-specific or third-party 
origin caused significant prolongation of transplant function 
and recipient survival in about one-fourth of the experiments. 
This was apparent confirmation of earlier claims by Jolley et 
al. (4) and others (1, 7). Since then, similar results have been 
described with animal RNA or even yeast RNA by some 
investigators (5, 6, 9, 11) but not by all (2). Because of the 
potential importance of such graft pretreatment, we have re-
peated our original investigations and have not been able to 
confirm them. 
The RNA was prepared with modifications of a standard 
technique (10) from fresh third-party mongrel dog spleens that 
were passed through a meat grinder. Aliquots were placed in 
glass vials and quick-frozen in a Dry Ice-acetone mixture. The 
frozen samples were kept at -20 C until the extraction proce-
dure. The frozen spleen was homogenized with cold Tris-
EDT A-buffered saline, 1% mercaptoethanol, and redistilled 
phenol. After centrifugation the aqueous layer was reextracted 
with phenol, and then precipitated with ice-cold absolute 
ethanol. The mixture was kept at -20 C overnight. The precip-
itate was dissolved in Tris-EDTA-buffered saline and reprecip-
ita ted with absolute ethanol to remove any remaining phenol. 
The final precipitate showed the characteristic ultraviolet ab-
sorption for RNA with a mean 280- to 260-nm ratio for all 
samples of 1:l.99. The protein content was less than 0.1%. RNA 
was quantitatively measured by the Orcinol procedure for pen-
tose. The RNA was added to lactated Ringer's solution in 
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amounts of 10 mg/100 ml and the pH was adjusted to 7.45 
before perfusion into the kidney grafts, 
Renal transplantation in mongrel dogs was the test model. A 
donor animal gave one kidney to a test recipient and the other 
kidney to a control. In two of the 14 experiments and in three 
of the controls, the organs were perfused with 400 ml of cold 
lactated Ringer's solution for about 70 min using a commercial 
renal preservation unit (Waters Instruments, Inc., Rochester, 
Minnesota). The amount of RNA added to the perfusate in the 
experimental group averaged 106.2 mg. In the other 12 experi-
mental kidneys, approximately the same amount of RNA was 
TABLE 1. Effect of RNA infusion on renal homograft survival values 
given in mean days ± SD 
--------- ._----
No. 
Survival 
Control 
14 
11.64 ± 2.92 
Experimental 
14 
9.5 ± 2.2 
added to 200 ml of lactated Ringer's solution and used to slowly 
infuse the organs over a 20-min period. These kidneys as well 
as those infused with unmodified lactated Ringer's solution 
were stored in the refrigerator at 10 C for an additional hI' in 
the same way as described by Groth et al. (3). 
Animals that died in less than 5 days were excluded from 
statistical computations since intussusception, respiratory com-
plications, and technical imperfections were the usual causes of 
early death. This necessitated eliminating about 30% of the 
recipients, almost equally divided between the test and control 
animals. 
The survival of animals that lived at least 5 days was the 
same statistically with or without RNA in the infusate (Table 
1). The actual survival was somewhat longer in the control 
series, but the difference was not significant. 
Histopathological examination of the control and RNA in-
fused kidneys revealed no differences. 
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This investigation thus failed to confIrm a potentially prom-
ising observation. It was not apparent why the results were 
different in 1975 and 1976 than in 1967 and 1968. Possibilities 
include a difference in the quality or quantity of RNA used, or 
more likely some systematic artifact in laboratory procedure or 
animal care that was present in our laboratory at an earlier 
time but not today. However, the best possibility is that our 
original observations led us to invalid conclusions. More re-
cently, it has been better appreciated that mongrel dog recipi-
ents not infrequently have long survival with no treatment at 
all (8). The fortuitous inclusion of a few such long-term surviv-
ing recipients in the test groups but not in the controls of our 
previous RNA work could thus have been misinterpreted. 
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